Forums and Workshops (September 11) - ET (Eastern Time, GMT-05:00)
Forums and Workshops (September 11) - ET (Eastern Time, GMT-05:00)
Chaired private and exclusive roundtable series.
11am (1hr 40mins) Roundtable One
- M&A, deal environment, anti-trust landscape analysis, general discussion and peer commentary from BD heads
11am Introductions
11.15 Current and Impending Anti-trust and Regulatory Threats
General Discussion and Peer Perspectives
- Perceptions and perspectives on current deal making environment: what are BD heads observing and how are they responding?
- How should big pharma M&A strategies evolve given the regulatory and anti-trust context?
For further information regarding the Pharma BD Leaders Forum, please contact:
Matthew Pullan, Managing Director, LSX
13.40pm (2hrs) Roundtable Two – Global BD Heads only
Pier discussion and exploration of solutions to presented challenges.
Potential topics to include:
- IRA developments
- M&A landscape
- Current challenges and success stories
- Anti-trust
- Regulatory update
- AI and relevance, impact on dealmaking
For further information regarding the Pharma BD Leaders Forum, please contact:
Matthew Pullan, Managing Director, LSX
The LSX Biotech Growth CEO Forum provides a unique, powerful and valuable space for the candid sharing of ideas and experience between 15-25 c-suite executives from privately-held biotechs at the post series A/pre series B stage, and also at the private post series B stage. The forum is designed to foster new ideas and create new relationships between attendees so that they can leave with tangible outcomes and that will drive their businesses and the sector forward.
The forum is an in-person c-suite forum where all participants are active discussants. It follows a strict Chatham House Rule policy and includes presentations, case studies and general discussion focused on brainstorming solutions to the current collective challenges of the group.
The forum is an invitation-only CEO forum where all participants are active discussants. It follows a Chatham House Rule policy and includes presentations, case studies and general discussion focused on brainstorming solutions to the current collective challenges of the group.
The forum features interactive peer review discussions from CEOs and Partners who put forward informative presentations or specific case studies, either success stories or current challenges, and the group asks questions and discusses the challenges around the topic, as well as solutions and ideas.